There is some debate over whether this qualifies as a blue-collar job. After all, ATCs usually earn more than $100,000 per year, work in an office-type surrounding, and supervise airline pilots, who themselves earn six-figure salaries.
Good news everyone! The Patent Office has granted a patent on a cure for cancer. Last December, the Patent Office issued Patent No. 8,609,158 on a âpotent drugâ that ârebukes cancer, cancer cells, and kills cancer.â According to the patent, this drug cures a litany of other maladies.
The new drugs are mainly aimed at patients with so-called solid tumors suffering from diseases including lung cancer and liver cancer. Lung cancer, the most common type, claims 1.8 million new cases each year worldwide. Sales of drugs to block PD-1 could reach $33 billion a year by 2022, according to Morningstar. New data published on Friday showed that Opdivo was most helpful to lung cancer patients with the highest levels of PD-L1 in their tumors, adding to evidence of a link.